Recent

% | $
Quotes you view appear here for quick access.

VIVUS Inc. Message Board

  • captain_nopants captain_nopants Feb 28, 2014 2:29 PM Flag

    VVUS has over $340 mil cash and $200 mil debt; Market cap around $600 Mil

    What is the #$%$ about debt? There is no debt issue....Qsymia missed revenue target mainly because of VVUS's lack of marketing ability and not having big-pharma partnership...they thought they have another Lipitor type of blockbuster so they didn't go for a partnership...Qsymia just starting to catch-up, especially Aetna deal is significant...most doctors don't have a way to prescribe or sample Qsymia until now...VVUS messed on marketing...Qsymia is incredible potential despite side-effects....remember Fen-Phen sold like crazy years back...VVUS formulated so they are sitting on a gold-mine!

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
VVUS
2.310.00(0.00%)May 4 4:00 PMEDT